{
  "generated": "2025-11-06T07:07:45.018549+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/psychological/inositol-ment-gen-0290/mental_health/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MENT-GEN-0290_01",
      "year": 2013,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "anxiety",
      "population": "Adults with anxiety concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/inositol-ment-gen-0290-01",
      "url": "https://doi.org/10.1234/inositol-ment-gen-0290-01",
      "citation": "MENT-GEN-0290_01 (2013); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with anxiety concerns; Outcome: anxiety; DOI: 10.1234/inositol-ment-gen-0290-01; Adverse Events: Transient headache."
    },
    {
      "study_id": "MENT-GEN-0290_02",
      "year": 2014,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "anxiety",
      "population": "Adults with anxiety concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/inositol-ment-gen-0290-02",
      "url": "https://doi.org/10.1234/inositol-ment-gen-0290-02",
      "citation": "MENT-GEN-0290_02 (2014); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with anxiety concerns; Outcome: anxiety; DOI: 10.1234/inositol-ment-gen-0290-02; Adverse Events: Transient headache."
    },
    {
      "study_id": "MENT-GEN-0290_03",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "anxiety",
      "population": "Adults with anxiety concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/inositol-ment-gen-0290-03",
      "url": "https://doi.org/10.1234/inositol-ment-gen-0290-03",
      "citation": "MENT-GEN-0290_03 (2015); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with anxiety concerns; Outcome: anxiety; DOI: 10.1234/inositol-ment-gen-0290-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/inositol-ment-gen-0290-01",
      "study_ids": [
        "MENT-GEN-0290_01"
      ],
      "primary_study_id": "MENT-GEN-0290_01",
      "url": "https://doi.org/10.1234/inositol-ment-gen-0290-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/inositol-ment-gen-0290-02",
      "study_ids": [
        "MENT-GEN-0290_02"
      ],
      "primary_study_id": "MENT-GEN-0290_02",
      "url": "https://doi.org/10.1234/inositol-ment-gen-0290-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/inositol-ment-gen-0290-03",
      "study_ids": [
        "MENT-GEN-0290_03"
      ],
      "primary_study_id": "MENT-GEN-0290_03",
      "url": "https://doi.org/10.1234/inositol-ment-gen-0290-03"
    }
  ],
  "manifest_hash": "sha256:252e89ec9ced1964ffc034a0b4cd34f1b928df5192dbef55e28dd7088c9202de"
}
